SARS-CoV-2 isolation and propagation from Turkish COVID-19 patients

土耳其 COVID-19 患者中 SARS-CoV-2 的分离和传播

阅读:11
作者:Cihan TaŞtan, Bulut Yurtsever, Gözde Sir KarakuŞ, Derya Dİlek KanÇaĞi, Sevda Demİr, Selen Abanuz, Utku Seyİs, Mülazim Yildirim, Recai Kuzay, Ömer Elİbol, Serap Arbak, Merve AÇikel Elmas, Selçuk BİrdoĞan, Osman Uğur Sezerman, Ayşe Sesin KocagÖz, Koray YalÇin, Ercüment Ovali

Abstract

The novel coronavirus pneumonia, which was named later as coronavirus disease 2019 (COVID-19), is caused by the severe acute respiratory syndrome coronavirus 2, namely SARS-CoV-2. It is a positive-strand RNA virus that is the seventh coronavirus known to infect humans. The COVID-19 outbreak presents enormous challenges for global health behind the pandemic outbreak. The first diagnosed patient in Turkey has been reported by the Republic of Turkey Ministry of Health on March 11, 2020. In May, over 150,000 cases in Turkey, and 5.5 million cases around the world have been declared. Due to the urgent need for a vaccine and antiviral drug, isolation of the virus is crucial. Here, we report 1 of the first isolation and characterization studies of SARS-CoV-2 from nasopharyngeal and oropharyngeal specimens of diagnosed patients in Turkey. This study provides an isolation and replication methodology,and cell culture tropism of the virus that will be available to the research communities.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。